Why the study?
Does cardiac-restricted overexpression of Bcl-2 prevent adverse cardiac remodeling and cardiomyocyte apoptosis in transgenic mice with cardiac-restricted overexpression of TNF?
Population
Transgenic mice with cardiac-restricted overexpression of secretable TNF (MHCsTNF)
Comparison
Cardiac-restricted overexpression of Bcl-2 vs MHCsTNF mice without Bcl-2 overexpression
Design
Preclinical
Authors
Loading...
Bcl-2 overexpression alone insufficient to block TNF-driven apoptosis in mice; hypothesis-generating for multi-pathway targeting in inflammatory cardiomyopathy.
Does cardiac-restricted overexpression of Bcl-2 prevent adverse cardiac remodeling and cardiomyocyte apoptosis in transgenic mice with cardiac-restricted overexpression of TNF?
Sustained TNF-induced inflammation activates multiple cell death pathways in cardiomyocytes, and blocking the intrinsic pathway alone with Bcl-2 is insufficient to fully prevent apoptosis, highlighting the complexity of adverse cardiac remodeling.
Haudek et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: